Abbreviations: FeNO, exhaled nitric oxide; IL-8, interleukin-8; MMP-9, metalloproteinase-9; TIMP-1, tissue inhibitor metalloproteinase-1; NF-jB, nuclear factor kappa B.
Introduction
Bronchial asthma is defined as a chronic inflammatory disease of the airways. The presence of chronic inflammation is associated with bronchial obstruction and with structural changes of the airways, i.e. bronchial remodeling (1) . The assessment of Ôasthma controlÕ as well as the definition of the severity of the disease by the current guidelines are based only on symptoms, short-acting b 2 -agonists use, and on measures of lung function (2) . No inflammatory parameters are presently taken into account although often symptoms are not specific and not closely related to the presence and severity of airway inflammation (3) .
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Rosalia Gagliardo 1 , Stefania La Grutta 1,2 , Pascal Chanez 3,4 , Mirella Profita 1 , Alessandra Paternò 5 , Fabio Cibella 1 , Jean Bousquet 4 , Giovanni Viegi 1 and Mark Gjomarkaj 1 sputum in detecting airway inflammation in asthmatic patients (7) (8) (9) (10) . FeNO is associated to respiratory symptoms, lung function, bronchial responsiveness, blood eosinophilia and it has been already demonstrated, both in adults and children, that a strategy based on the measurement of FeNO or sputum eosinophilia allows to avoid asthma exacerbations, to reduce inhaled corticosteroids requirement and to improve airway hyperresponsiveness (11, 12) .
Most of the mediators related to asthma inflammation and remodeling, including Interleukin-8 (IL-8), Metalloproteinases (MMPs), and inhibitors of metalloproteinase (TIMPs), can be measured in the supernatant of induced sputum (13, 14) . IL-8, has been shown to play an important role in adult and childhood asthma, and despite continuous long-term treatment with systemic and inhaled glucocorticoids (GC), high levels of IL-8 are synthesized by airway cells and peripheral blood mononuclear cells (PBMC) of severe uncontrolled asthmatics (15, 16) , and moderate persistent asthmatic children where IL-8 is correlated with the occurrence of exacerbations (6) . MMPs and TIMPs, are important mediators of inflammation, cytokine activation, and tissue remodeling. The balance between MMPs and the TIMPs plays an important role in the breakdown and deposition of extra-cellular matrix (ECM) in the airways wall representing an important cause of airflow limitation in asthma (17) . Although the major source of MMP-9 in the lung is represented by macrophages, followed by neutrophils and epithelial cells, high levels of active MMP-9 have been also demonstrated to be released by eosinophils in asthmatic airway inflammation (18) and in eosinophilic asthma (19) . IL-8 has been shown to induce the release of MMP-9 from neutrophils, and in turn MMP-9 can increase IL-8 potency (20) . In this context, it was observed that the transcriptional factor NF-jB, which plays a role in the persistence of inflammation (21) , regulates IL-8 (22) and MMP-9 (23) gene expression and is in part responsible (via IKK/NF-jB pathway) of the TIMP-1 gene regulation (24) .
We hypothesized that markers of inflammation or remodeling in induced sputum may mirror asthma severity and control in asthmatic children. For this reason, we undertook a prospective follow-up study in children with intermittent asthma (IA), and moderate asthma (MA), who were clinically and functionally well controlled and were receiving medium doses of inhaled corticosteroids and long-acting b 2 agonists. We aimed to investigate the Ôinflammatory statusÕ of these patients using non-invasive methods including induced sputum biomarkers measurements (number of eosinophils, IL-8, MMP-9, TIMP-1 and p65 NF-jB subunit), concomitantly with FeNO. Finally, we evaluated whether these biomarkers were correlated with the development of disease exacerbations throughout an 1-yr follow-up period of time.
Materials and methods Subjects
Forty-three asthmatics (6-14 yr, mean s.d.: 9.2 ± 2.5) were recruited from the outpatient clinic of the children hospital ARNAS in Palermo, Italy. The diagnosis of asthma and the assessment of its severity and control were done at study entry according to Global Initiative for Asthma (25) . Only 35 of 43 asthmatic children were able to obtain suitable sputum samples at visit 1 and to be included in the study. All these included subjects were able to perform induced sputum at visit 3, either on the scheduled day of visit 3 or within 1 wk from it.
Twelve children had intermittent asthma, treated with short-acting b 2 agonists on demand during the last 3 months; 23 children had moderate asthma treated with fluticasone propionate 250 lg [inhaler device Diskus (GlaxoSmithKline, Brentford, UK)] plus Salmeterol 50 lg bid, for at least 3 months. This high dose of Fluticasone was used to stabilize these patients and to let them have a ÔcontrolledÕ disease, at least considering the clinical and functional parameters. The control group consisted of nine healthy children. Throughout a longitudinal 1-yr follow-up study, the visits 1, 2, 3 and 4 were scheduled every 4 months. The study was approved by the Institutional Ethical Committee. All parents of the children signed a written informed consent.
Clinical assessment and compliance of patients
Pulmonary function tests were performed as recommended by the American Thoracic Society (26) . Forced expiratory volume in 1 s (FEV 1 ), forced vital capacity (FVC) were measured according to ATS guidelines and the best of three technically acceptable and reproducible maneuvers was retained (26) . Atopic status was assessed by skin-prick tests (27) to aeroallergens commonly present in the Mediterranean area, and total serum IgE measurements. The compliance to treatment was assessed by checking the inhalation technique at each visit. We also measured basal plasma cortisol concentrations at 8:00 am by electrochemiluminescence twice (visits 1 and 4). Results were expressed in nanomolar concentrations, and adherence to inhaled corticosteroids was considered satisfactory if cortisol was less than 100 nm (28, 29) . To accurately monitor the patientsÕ symptoms, at the beginning of the study parents were provided with cell phone numbers of phisicians who were on call always reachable 24 h a day for the entire follow-up period. Parents were accurately instructed to refer to physicians about any symptoms occurred. When symptoms possibly related to putative exacerbations occurred, on the basis of physicianÕs evaluation, patients underwent unscheduled visits on the same or on the following day, in order to verify the effective presence and to classify and treat the exacerbations. Asthma exacerbations were defined as increasing symptoms and signs of asthma (coughing, wheezing, shortness of breath) unresponsive to the patientÕs routine asthma medication and requiring an unscheduled visit. Mild and severe exacerbations were differentiated according to the Formoterol and Corticosteroids Establishing Therapy study (30) . Severe exacerbations were treated with a short course of oral steroids (1 mg/ kg of prednisolone for 2-5 days). The number of mild and severe exacerbations occurred during the follow-up period was recorded. Moderate asthmatic children were divided into two subgroups on the basis of the frequency of severe exacerbations (31) .
Nitric oxide measurement
FeNO was determined by a chemiluminescence analyzer connected to a computerized system (NIOX; Aerocrine AB, Solna, Sweden), and measured in triplicate after fast inhalation maneuvers to total lung capacity, at a constant flow rate of 50 ml/s (32) . The mean of three measures was retained for the analysis.
Sputum induction
Each subject underwent spirometry before the beginning of the procedure. If FEV 1 was over 75% of predicted at baseline and the child had not used a short-acting b2-agonist within the last 6 h, we performed the procedure without premedication. Patients were exposed to an aerosol of 4% hypertonic saline solution, monitoring the assessment of bronchial reactivity, as described elsewhere (33) .
Sputum processing
Sputum processing was performed according to the methods of Hargreave et al. with minor modifications (34) . The cells obtained from induced sputum were then cytocentrifuged (Cytospin 2; Shandon Instruments, Runcorn, UK) and stained with Diff-Quick (Merz-Dade, Dudingen, Switzerland (CH)). Slides were read blindly by two independent investigators and differential cell counts were expressed as a percentage of 400 cells.
Measurement of IL-8, MMP-9, TIMP-1
Evaluation of IL-8, MMP-9, and TIMP-1 concentrations in induced sputum supernatants was assessed using commercially available specific enzyme-linked immunoadsorbent assay kits (R&D Systems, UK; Biotrack, Amersham International plc, UK) according to the manufac-turerÕs instructions.
Immunocytochemistry analysis
To further characterize the ongoing bronchial inflammation in both groups of asthmatics, we performed immunocytochemical analyses in sputum cells to determine the subcellular distribution of p65 NF-jB subunit. After thawing, immunoreactivity for p65 NF-jB subunit, was evaluated using the labeled streptavidin-biotin method (Alkaline phosphatase Rabbit/Mouse/ Goat; Universal LSAB + kit; Dako, Glostrup, Denmark), as previously described (21) . The cell identification was based on cell morphology under light microscopy (·400 final magnification), carefully referring to the cell type distribution in corresponding Diff-Quick-stained slides. p65 localization was expressed as percentage of sputum cells showing a p65 nuclear staining. Goat polyclonal anti-p65 NF-kB subunit (Santa Cruz Biotechnology, Santa Cruz, California) was diluted 1:20.
Study design
After 1 month run-in period, during which FEV 1 before and after broncho-dilation (400 lg of salbutamol) was assessed, patients attended the outpatient clinic (visit 1) and underwent clinical assessment (pre-and postbronchodilator FEV 1 ) after 4 (visit 2), 8 (visit 3) and 12 (visit 4) months by the same physician (S.L.G) ( Fig. 1 ). In patients with an upper respiratory tract infection, follow-up visits were postponed for 2 wk. Biomarkers and FeNO levels were measured at visit 1 and at visit 3. Sputum eosinophilia, IL-8, MMP-9, and TIMP-1 sputum concentrations were measured in nine controls (C), 12 IA and 23 MA children. p65 nuclear localization was evaluated in group subsets, owing to limitation in the amount of sputum cells recovered, in 6 out of 9 C, 8 out of 12 IA and 12 out of 23 MA children.
Statistical analysis
As variables were normally distributed, analysis of variance (anova) was used for between-group comparisons with BonferroniÕs correction for multiple comparisons. Correlations were analyzed by linear regression analysis and multiple linear regression analysis model.
Results

Demographic and functional characteristics of patients
The demographic and functional characteristics of patients are reported in Table 1 . No statistically significant differences were found among the three study groups in terms of FEV 1 values at all visits indicating that, on the basis of this parameter, the asthmatic patients were functionally under control. We observed a significant FEV 1 /FVC decline in MA in comparison with C, and in MA in comparison with IA at all visits. In IA a significant FEV 1 /FVC decline in comparison to C was observed only at visits 2 and 4 ( Table 1 ). In IA 25 exacerbations occurred (mean 2.1 exacerbations per patient), 24 of which mild and 1 severe. In MA 73 exacerbations occurred (mean 3 exacerbations per patient), 43 of which mild and 30 severe.
FeNO and eosinophil number measurements
The levels of FeNO and the number of sputum eosinophils were significantly increased in IA and MA in comparison with C at both visits 1 and 3, whilst no significant differences were detected between the two groups of asthmatics ( Table 1) .
Detection of IL-8, MMP-9, TIMP-1
We measured the concentrations of IL-8, MMP-9, and TIMP-1 in the induced sputum supernatants recovered from the three groups of subjects at visits 1 and 3. The concentrations of IL-8 (Fig. 2) , MMP-9 and TIMP-1 (Fig. 3 , a-b) were significantly increased in the two groups of asthmatics when compared with controls at both visits 1 and 3. No significant differences were detected in terms of MMP-9/TIMP-1 molar ratio at both visits 1 and 3 among the three study groups (Fig. 3c) . No significant differences were present comparing the levels of each specific mediator at visit 1 and 3 (Figs 2 and 3 ).
Total and differential cell counts in induced sputum samples
The percentage of eosinophils was significantly higher in IA and MA than in C (p < 0.0005) ( Table 2 ). The IA and MA also had a significantly increased percentage of neutrophils and a significantly decreased percentage of macrophages when compared with C ( Table 2 ). The median viability of the cells obtained from induced sputum samples was 78% (25 to 75 percentiles: 70 to 85) in C and 72% (25 to 75 percentiles: 65 to 80) in asthmatic children.
Subcellular distribution of p65 NF-jB subunit
The percentage of induced sputum cells with a p65 nuclear staining (p65 localization was expressed as percentage of sputum cells showing a p65 nuclear staining) was significantly higher in IA and MA than in C (p < 0.0005) ( Table 3 ).
The percentage of macrophages, eosinophils and neutrophils of sputum cells with a positive p65 nuclear staining was significantly higher in IA and MA than in C, at both visits 1 and 3. No differences were detected between the two groups of asthmatic patients ( Table 3) . R 2 = 0.66; p = 0.004, R 2 = 0.4, respectively) in MA. In this group of subjects, a positive correlation was also present between the number of sputum eosinophils and MMP-9 and TIMP-1 (p = 0.04, R 2 = 0.25; p = 0.01, R 2 = 0.3, respectively). The number of severe exacerbations occurred in MA during the follow-up significantly and positively correlated with the levels of FeNO (Fig. 4a ), the number of eosinophils (Fig. 4b) , and the sputum concentrations of IL-8 at both visits 1 (Fig. 4c ) and 3 (data not shown). When a multiple linear regression analysis was performed between severe exacerbations as dependent variable and FeNO, eosinophils and IL-8 as independent variables, the R 2 value showed a marked increase (0.79) compared with single linear regressions. On the basis of the number of severe exacerbations occurred during the followup, it was possible to identify two distinct subgroups of patients with MA classified as frequent exacerbators ( ‡2 exacerbations, n = 10) and infrequent exacerbators (0 or <2 exacerbations, n = 13). The FeNO levels (Fig. 4d ), the number of sputum eosinophils (Fig. 4e ) and the IL-8 sputum concentrations ( Fig. 4f ) measured in the frequent exacerbators were significantly higher than in the infrequent exacerbators. No significant correlation was found between MMP-9, TIMP-1, and the MMP-9/TIMP-1 molar ratio and the number of severe exacerbations.
The number of sputum eosinophils (data not shown), and IL-8 concentrations (Fig. 5a ) positively correlated with the asthma duration (p = 0.04, R 2 = 0.25; p = 0.01, R 2 = 0.25, respectively), while IL-8 concentrations inversely correlated with FEV 1 /FVC (p = 0.01, R 2 =0.36) ( Fig. 5b) in MA. In addition, when IA and MA were grouped together, the number of total exacerbations, regardless severity, at both visits 1 and 3, significantly correlated with sputum eosinophilia (p = 0.03; R 2 = 0.4; p = 0.04; R 2 = 0.36, respectively), and IL-8 levels (p = 0.01; R 2 = 0.43; p = 0.02; R 2 = 0.4, respectively), but not with FeNO levels (data not shown). No significant correlations were found between total number of exacerbations and MMP-9, TIMP-1, and MMP-9/TIMP-1 molar ratio. MMP-9 positively correlated with IL-8 levels (p < 0.0001, R 2 = 0.46). 
Discussion
This study shows that the levels of several biomarkers, including IL-8, MMP-9, TIMP-1, number of eosinophils in induced sputum as well as the levels of FeNO, are increased in children with IA and MA as compared to C and that, according to the levels of FeNO, number of eosinophils, and IL-8 sputum concentrations, two different phenotypes of MA children can be identified. These three latter markers correlate, in MA, with the occurrence of disease exacerbations during a 1-yr follow-up period of time. Treatment with ICS reduces FeNO by a direct effect on transcription of inducibile NO synthase (35, 36) and, accordingly, FeNO has been proposed as a sensitive non-invasive and reproduc-ible marker of asthma activity that well correlates with eosinophilic airway inflammation (37) . These findings suggest the possibility to use this methodology in children to monitor the efficacy of the therapy on this specific parameter, although recent studies showed that a therapy regimen aimed to lowering FeNO in children with asthma improved parameters of small airways function but was not able to improve clinical markers of asthma control (38) . In this context, we observed increased levels of FeNO and sputum eosinophils in children with IA and MA when compared with C while no significant differences were observed between both groups of asthmatics during the 1-yr follow-up. Since it has been demonstrated a heterogeneity of FeNO response to ICS (39) and since FeNO indicates the severity and the control of childhood asthma (40) the observed absence of a significant difference in oral FeNO between children with IA and MA demonstrates that, despite the use of ICSs, increased levels of oxidative stress markers, as well as elevated eosinophils levels, persist in some of these patients. Our findings that FeNO is increased in a subgroup of MA patients confirm previous observations and extend them providing new information on the usefulness of the use of this marker in monitoring bronchial inflammation in asthma. Moreover, these findings support the concept of the presence of different phenotypes of asthmatic patients detectable using noninvasive methods including FeNO measurement. IL-8 has been shown to play an important role in the airways and in the systemic circulation of both adulthood (16, 41) , and childhood asthma (6) . High levels of IL-8 are synthesized from PBMC of adult severe asthmatics (16) , and moderate persistent asthmatic children with significant differences when compared with intermittent asthmatic children (6) . An increase in the expression of IL-8 was observed in the airway mucosa of adult moderate-to-severe asthmatics (41) as well as in the induced sputum supernatants of adult severe asthmatics showing an elevated grade of neutrophilia (15) despite these patients were receiving ICS therapy (41) . In addition, increased levels of IL-8 were observed in induced sputum (42) of children with acute asthma. In this context there were not clear evidences about the effects of ICS on the reduction of the levels of IL-8 in the airways of asthmatic children. The present study extends these findings at bronchial levels of IA and MA children showing increased levels of IL-8 in induced sputum supernatants when compared with C. Although no significant differences were observed between IA and MA children during the follow-up, we observed the presence of two sub-groups of MA children: one showing a reduction of IL-8 levels and another group showing the presence of high levels of IL-8 suggesting the presence of bronchial inflammation despite the regular ICS treatment. These observations support the concept of heterogeneity of bronchial asthma in MA children (6, 39) and, once again, suggest the presence of different phenotypes of MA children.
Airway remodeling, traditionally referred to the advanced steps of the disease (14) , has been shown to be present very early in the course of childhood asthma (43) . For this reason, it is important to assess the relationships between airway inflammation and remodeling and the clinical spectrum of asthma severity in children. We investigated MMP-9 and TIMP-1 in induced sputum of asthmatic children and we found that MMP-9 and TIMP-1 are significantly increased in both IA and MA in comparison with C at both visits 1 and 3 while no differences were present between IA and MA children. We did not find any significant reduction of MMP-9/TIMP-1 molar ratio in these patients in comparison to C, although in adult asthmatic patients the MMP-9/TIMP-1 molar ratio is lower than in control subjects, suggesting a trend toward fibrosis due to the existence of a proteaseantiprotease imbalance (14) . The absolute concentration of TIMP-1, and not its molar ratio with MMP-9, has been shown to be associated with persistent wheezing in atopic preschool children (44) . Consistently, in our asthmatic children the observed increased concentrations of MMP-9 and TIMP-1 suggests that some proremodeling mediators are present at least in a subgroup of children although in the absence of a protease-antiprotease imbalance. These findings suggest that the remodeling process in some children might be already initiated at the early steps of the disease, although the effects are not yet defined.
IL-8 promotes neutrophil and eosinophil infiltration in the lung (45) , leading to chronic inflammation. MMP-9 is released by macrophages, epithelial cells and eosinophils, and TIMP-1 is the major tissue inhibitor secreted in association with MMP-9. Consistently with this, it has already been found a close relationship between levels of IL-8 and MMP-9 in sputum of adult asthmatics as well as a deficiency of antiproteases mechanisms in the same patients (19) . In addition, it has been demonstrated that IL-8 is a substrate for activated MMP-9 and the resultant MMP-9modified IL-8 molecule is more potent in promoting cell activation (20) . Our findings showing a positive correlation between IL-8 and MMP-9 and TIMP-1, and between sputum eosinophils and MMP-9 and TIMP-1, suggest that remodeling mediators may be released simultaneously with inflammatory mediators other than consecutively in asthmatic children. Moreover, the presence of a link between these two events together with the identification of a sub-population of MA with high sputum concentrations of IL-8 which undergoes a higher number of exacerbations during the follow-up suggest that, despite regular treatment, some patients are not controlled in terms of both bronchial inflammation and disease management. The data generated here provide new information for the identification of these specific phenotypes of MA.
In both adults and children with moderate to severe asthma, it has been demonstrated a persistent activation of NF-jB system due to an over-expression of p65 subunits and to an increased p65-DNA complex formation (6, 21) . We provide evidences that the percentage of sputum cells with a p65 nuclear localization is higher in children with IA and MA than in C at both visits 1 and 3, accordingly with IL-8, MMP-9 and TIMP-1 sputum levels. Moreover, the persistence of the activation of NF-jB pathway in the two groups of asthmatic children, supports the concept that, despite the ongoing ICS therapy, some patients display not completely inhibited molecular mechanisms of airway inflammation. These results confirm and extend some previous observations by our group obtained, at systemic level, in moderate persistent asthmatic children (6) . Although we did not identify any correlations between p65 and IL-8, MMP-9 and TIMP-1, the increased p65 nuclear localization in sputum cells suggests that the activation of NF-jB system sustains the ongoing production of pro-inflammatory and remodeling mediators also in the airways of these asthmatic children, as previously demonstrated in adults (21) .
The use of FeNO measurement and the performance of induced sputum allows to longitudinally assess bronchial inflammation in asthmatic children and to investigate whether the detection of some biomarkers could provide additional information useful in the control and management of the disease. Our findings demonstrating that the number of sputum eosinophils and IL-8 sputum concentrations in IA and MA, correlate with the number of total exacerbations (mild and severe exacerbations) occurred during the follow-up suggest that these inflammatory markers are associated with the disease activity. In addition, in MA, we found that FeNO, eosinophilia, and IL-8 levels significantly correlate with the number of severe exacerbations, indicating the presence of a subclinical inflammation leading to a lack of disease control. According to the levels of these three biomarkers two different subgroups of MA can be identified: the frequent (>2/yr) and the infrequent (0 or <2/yr) exacerbators. It was already shown, in adults, that a strategy based on the measurement of FeNO or on sputum eosinophils permitted to avoid asthma exacerbations and to reduce inhaled GC requirement (11, 12) . The findings that the Ôfrequent exacer-batorsÕ show increased FeNO levels, sputum eosinophilia and increased IL-8 sputum levels extend these previous observations to a pediatric population and further support the link between these markers of inflammation and asthma control and the occurrence of severe exacerbations. Similar results were obtained by Pijnenburg et al. showing that FeNO is an early predicting marker of relapse in asthma after cessation of ICS (46) . According to this concept, we observed in MA a positive correlation between IL-8 sputum concentrations and asthma duration. Furthermore, the persistent production of IL-8 may also indicate a greater propensity of the Ôfrequent exacerbatorsÕ to develop severe asthma (16) and to switch to a neutrophilic inflammation which is often associated with this asthma phenotype (47) .
In this study, the markers of inflammation (i.e. FeNO, sputum eosinophilia and IL-8) correlate with inflammation-related events, such as asthma exacerbations, while the markers of remodeling do not. These latter markers might likely mirror a future development of the remodeling process.
In the present study, we did not find any differences in terms of FEV 1 measurements among the three study groups and the long-term follow-up confirmed the initial clinical assessment of the children. Our finding of lack of significant decrease of FEV 1 levels in patients with asthma is consistent with the Bacharier study (48) where this is also valid even in moderate to severe asthmatic children, especially among patients receiving asthma controller therapy. According to this latter study, we found that there is a gradient of decline in FEV 1 /FVC among children with increased asthma severity. These data suggest that FEV 1 /FVC could be more sensitive than FEV 1 for the detection of smooth differences of asthma severity. Accordingly, in MA we found an inverse correlation between FEV 1 /FVC and asthma duration, and between FEV 1 /FVC and IL-8 sputum concentrations.
The present study supports the importance to monitor bronchial inflammation to better control asthma in children. We have previously demonstrated that PBMC from some IA children, as well as PBMC from some MA children, were able to release inflammatory cytokines ex vivo. In particular, we showed that moderate asthmatic children can be differentiated into two subgroups according to biologic and clinical parameters, including IL-8 and GM-CSF released by PBMC, and that these markers could be useful to asses the clinical heterogeneity and the control of asthma in children (6) . The use of non-invasive procedures allowed us to increase and extend these previous findings by investigating the local bronchial inflammation and by evaluating some molecular mechanisms involved in the persistence of inflammation in induced sputum cells.
In conclusion, although the relatively small number of recruited subjects precludes from definitive conclusions on the clinical usefulness of these markers, this study shows that in moderate asthmatic children the inflammatory process is associated with biologic and clinical heterogeneity of the disease, despite regular glucocorticoid treatment. The association between pro-inflammatory and pro-remodeling mediators, could sustain the persistence of inflammation and probably promote the lack of disease control in a subgroup of moderate asthmatics. This study also proposes the need to perform large prospective studies to confirm the importance of measuring specific biomarkers in induced sputum, concomitantly to FeNO analyses, to assess airway inflammation, asthma control, and predictivity of exacerbations in children with asthma.
